Understanding immune responses to develop vaccines and treatments for infectious diseases
NIH TETRAMER CORE FACILITY (INFECTIOUS DISEASES OTHER THAN HIV/AIDS)
This study is all about helping scientists learn more about how our immune system fights infections, so they can create better vaccines and treatments for everyone, including patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10268616 on NIH RePORTER |
What this research studies
This research focuses on enhancing our understanding of how the immune system responds to infectious diseases, which is crucial for developing effective vaccines and therapies. It involves the synthesis and distribution of specialized reagents known as MHC tetramers, which help researchers study immune responses in detail. By providing these resources, the research aims to support biomedical researchers globally in their efforts to combat infectious and immune-mediated diseases. Patients may benefit indirectly through advancements in treatment options and public health improvements.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by various infectious diseases or those at risk of such conditions.
Not a fit: Patients with non-infectious diseases or those not involved in the immune response may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new vaccines and therapies that improve prevention and treatment of infectious diseases.
How similar studies have performed: Previous research has shown success in using MHC tetramers to study immune responses, indicating that this approach is well-established and promising.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Altman, John — Emory University
- Study coordinator: Altman, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.